Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Japan Earnings Roundup: Astellas' Oncology Gains, Eisai Hit Hard, KHK Domestic Strength

Nov 08 2011

• By Daniel Poppy

Related Content

Kyowa Hakko Kirin Pins Rebound On KW-0761 For Oncology And Allergy Indications

Jul 29 2010

Medivation Gets $110M Upfront From Astellas In Prostate Cancer Collaboration

Oct 30 2009

Daiichi Sankyo's Edoxaban Enters Its First Market; Eisai "Very Pleased" With Eribulin Japanese Price Listing

Jul 20 2011

Eisai's Perampanel Phase III Outcomes Show Efficacy, But May Not Meet Company Hype

Aug 31 2011

Japan Earnings Roundup: Eisai Update On FDA Refusal Letter; Specialty Pharma Santen Packs A Punch In China

Aug 04 2011

Japanese Earnings Roundup: Shionogi Rebounds From U.S. Acquisition Woes With C&O Pharmaceutical For China; Astellas Ponders Mirabegron's Reproductive Warning

Aug 02 2011

Related Companies

Astellas Pharma, Inc.

Medivation, Inc.

AVEO Pharmaceuticals, Inc.

Eisai Co., Ltd.

Kyowa Kirin Co., Ltd.

ProStrakan Group plc

Daiichi Sankyo Co., Ltd.

Amgen, Inc.

Additional Topics

Japan Asia Pacific BioPharmaceutical

More from Japan

More from Focus On Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window